141 related articles for article (PubMed ID: 34779502)
1. MicroRNA‑190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4.
Li Y; Wang Z; Zhao F; Zeng J; Yang X
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779502
[TBL] [Abstract][Full Text] [Related]
2. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y
Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of circulating miR 802-5p and miR 194-5p and upregulation of brain MEF2C along breast cancer brain metastasization.
Sereno M; Haskó J; Molnár K; Medina SJ; Reisz Z; Malhó R; Videira M; Tiszlavicz L; Booth SA; Wilhelm I; Krizbai IA; Brito MA
Mol Oncol; 2020 Mar; 14(3):520-538. PubMed ID: 31930767
[TBL] [Abstract][Full Text] [Related]
4. Methylation‑associated silencing of miR‑638 promotes endometrial carcinoma progression by targeting MEF2C.
Ni J; Liang S; Shan B; Tian W; Wang H; Ren Y
Int J Mol Med; 2020 Jun; 45(6):1753-1770. PubMed ID: 32186750
[TBL] [Abstract][Full Text] [Related]
5. The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer.
Hong L; Sun G; Peng L; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2018 Nov; 40(5):2916-2925. PubMed ID: 30226601
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
Li S; Yan G; Yue M; Kang Z; Wang L
Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
Yan J; Jia Y; Chen H; Chen W; Zhou X
J Exp Clin Cancer Res; 2019 Sep; 38(1):390. PubMed ID: 31488171
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-215 functions as a tumor suppressor and directly targets ZEB2 in human pancreatic cancer.
Li QW; Zhou T; Wang F; Jiang M; Liu CB; Zhang KR; Zhou Q; Tian Z; Hu KW
Genet Mol Res; 2015 Dec; 14(4):16133-45. PubMed ID: 26662405
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
Xu DF; Wang LS; Zhou JH
Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
11. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1.
Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑137 suppresses the proliferation, migration and invasion of cholangiocarcinoma cells by targeting WNT2B.
Chen T; Lei S; Zeng Z; Pan S; Zhang J; Xue Y; Sun Y; Lan J; Xu S; Mao D; Guo B
Int J Mol Med; 2020 Mar; 45(3):886-896. PubMed ID: 31985024
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.
Wang G; Pan J; Zhang L; Wei Y; Wang C
Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28940804
[TBL] [Abstract][Full Text] [Related]
15. miRNA-141, downregulated in pancreatic cancer, inhibits cell proliferation and invasion by directly targeting MAP4K4.
Zhao G; Wang B; Liu Y; Zhang JG; Deng SC; Qin Q; Tian K; Li X; Zhu S; Niu Y; Gong Q; Wang CY
Mol Cancer Ther; 2013 Nov; 12(11):2569-80. PubMed ID: 24013097
[TBL] [Abstract][Full Text] [Related]
16. MiR-345-5p functions as a tumor suppressor in pancreatic cancer by directly targeting CCL8.
Mou T; Xie F; Zhong P; Hua H; Lai L; Yang Q; Wang J
Biomed Pharmacother; 2019 Mar; 111():891-900. PubMed ID: 30841468
[TBL] [Abstract][Full Text] [Related]
17. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
[TBL] [Abstract][Full Text] [Related]
18. Exosomal MEF2C's Association With the Progression of CRC in Regulating CD36 Transcription.
Wang M; Jiang Y; Fan ZL; Zhang N; Liang J; Zheng Z
Altern Ther Health Med; 2023 Jan; 29(1):198-209. PubMed ID: 36074971
[TBL] [Abstract][Full Text] [Related]
19. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]